Nephroprotective effect of betamipron on a new carbapenem, DA-1131, in rabbits

Citation
Sh. Kim et al., Nephroprotective effect of betamipron on a new carbapenem, DA-1131, in rabbits, BIOPHARM DR, 20(3), 1999, pp. 125-129
Citations number
18
Categorie Soggetti
Pharmacology & Toxicology
Journal title
BIOPHARMACEUTICS & DRUG DISPOSITION
ISSN journal
01422782 → ACNP
Volume
20
Issue
3
Year of publication
1999
Pages
125 - 129
Database
ISI
SICI code
0142-2782(199904)20:3<125:NEOBOA>2.0.ZU;2-#
Abstract
The nephroprotective effect of betamipron (200 mg/kg) was evaluated after i ntravenous administration of a high dose of DA-1131 (200 mg/kg) to rabbits. Extensive tubular necrosis was observed without betamipron but the necrosi s was not observed with betamipron at 8 h after intravenous administration of DA-1131 based on kidney microscopy. By treatment with betamipron, the am ounts and tissue to plasma (TIP) ratios of DA-1131 in renal cortex and whol e kidney decreased significantly (65-91% decrease) at both 30 min and 2 h a fter intravenous administration of the drug to rabbits. This indicated that the accumulation of DA-1131. in rabbit renal cortex and whole kidney was i nhibited by betamipron. This resulted in significantly greater percentages of intravenous DA-1131 excreted in urine as unchanged drug, 60.9 versus 40. 1%, and significantly faster rend clearance (Cl-r) of DA-1131 (6.10 versus 3.22 mL/min/kg) by treatment with betamipron. By treatment with betamipron, the amounts and T/P ratios of DA-1131 in renal cortex and whole kidney dec reased significantly from 30 min and the renal function remained intact at 8 h after intravenous administration of DA-1131. The above data suggested t hat the nephroprotective effect of betamipron was fast and persisted for a long period of time in rabbits. Copyright (C) 1999 John Wiley & Sons, Ltd.